HKU Scholars Hub: Browsing DSpace

Browsing by Author Gish, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date	Views
	A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population Proceeding/Conference:Journal of Hepatology	Gane, E Schwabe, C Given, B Schluep, T Hamilton, J Lai, CL Locarnini, S Lau, J Ferrari, C Gish, R	2017	77
	Decline in hepatitis B surface antigen levels with entecavir treatment in HBeAg-positive nucleoside naive chronic hepatitis B patients-results from phase III study ETV-022 Proceeding/Conference:Gastroenterology	Gish, R Chang, TT Lai, CL De Man, RA Gadano, A Yu, S Llamoso, C Tang, H	2012	83
	HBV infection in immunocompromised patients Book:Human Virus Guides	Lau, G Gish, R Liang, RHS	2005	106
	Hepatitis B Surface Antigen Loss in Antiviral-treated Patients with HBeAg(+) Chronic Hepatits B (CHB) Infection: Observations from Antiviral-naive Patients Treated with Entecavir (ETV) or lamivudine (LVD) Proceeding/Conference:Hepatology	Gish, R Chang, TT Lai, CL de Man, R Gadano, A Poordad, F Zhu, J Yang, J Brett-Smith, H	2006	164
	Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment Journal:Gut	Yuen, MF Wong, DKH Schluep, T Lai, CL Ferrari, C Locarnini, S Lo, RCL Gish, R Hamilton, J Wooddell, CI Mak, LY Given, BD	2021	16
	Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Gane, E Locarnini, S Lim, TH Strasser, SI Sievert, W Cheng, W Thompson, AJ Given, BD Schluep, T Hamilton, J Biermer, M Kalmeijer, R Beumont, M Lenz, O Ridder, FD Cloherty, G Wong, DKH Schwabe, C Jackson, K Ferrari, C Lai, CL Gish, R Yuen, RMF	2022
	T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection Proceeding/Conference:Hepatology	Ito, K Tanaka, Y Sugiyama, M Fujiwara, K Sugauchi, F Orito, E Asahina, Y Tokita, H Yuen, RMF Lai, CL Acharya, SA Gish, R Mizokami, M	2005	131

Showing results 1 to 7 of 7